Korean J Intern Med.
2022 Sep;37(5):947-948. 10.3904/kjim.2022.261.
Denosumab, an effective osteoporosis treatment option for men
- Affiliations
-
- 1Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
- KMID: 2533137
- DOI: http://doi.org/10.3904/kjim.2022.261
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Denosumab for the treatment of osteoporosis
- Recent Update on RANKL Inhibitor
- Denosumab (RANKL Inhibitor): A Potent Anti-Resorptive Agent
- Cost-Effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in South Korea
- Update on Denosumab Treatment in Postmenopausal Women with Osteoporosis
